Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Emergent BioSolutions Inc. Common Stock
(NY:
EBS
)
8.150
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Feb 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Emergent BioSolutions Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
What's going on in today's pre-market session
↗
February 27, 2026
Via
Chartmill
Why Did Emergent Biosolutions Stock Tumble 20% After-Hours Today?
↗
February 27, 2026
The board authorized a new $50 million share repurchase program running through March 2027.
Via
Stocktwits
Topics
Earnings
Emergent BioSolutions Inc (NYSE:EBS) Shares Tumble on Weak Q4 Results and Cautious 2026 Outlook
↗
February 26, 2026
Via
Chartmill
Wondering what's happening in today's after-hours session?
↗
February 26, 2026
Via
Chartmill
Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results
February 26, 2026
From
Emergent BioSolutions
Via
GlobeNewswire
Earnings Scheduled For October 29, 2025
↗
October 29, 2025
Via
Benzinga
Emergent BioSolutions Announces Approximately $140 Million in Contract Awards with the Government of Canada, Strengthening Canada’s Leadership in Health Preparedness
February 26, 2026
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Announces New $50 Million Stock Repurchase Program
February 26, 2026
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Receives U.S. FDA Approval of Supplemental New Drug Application (sNDA) for NARCAN® Nasal Spray Multipacks
February 12, 2026
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
February 12, 2026
From
Emergent BioSolutions
Via
GlobeNewswire
Why Did EBS Stock Fall 13% Today?
↗
January 15, 2026
New York State Attorney General Letitia James inked a settlement with Emergent under which the company will pay $900,000 in penalties.
Via
Stocktwits
Topics
Law Enforcement
Lawsuit
Emergent BioSolutions Receives U.S. FDA Approval on Supplemental New Drug Application for NARCAN® Nasal Spray to be Packaged in a New Carrying Case, Making Life-Saving Naloxone More Accessible for Everyday Preparedness
January 14, 2026
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Announces $100 Million Paydown of Term Loan Principal, a Significant Step Achieved Toward its Multi-year Transformation
January 12, 2026
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026
January 08, 2026
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions and PANTHER Announce Agreement to Support the Continuation of the Africa CDC-led MpOx Study in Africa
January 08, 2026
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
January 07, 2026
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site
December 12, 2025
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access
November 18, 2025
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors
November 12, 2025
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions (EBS) Earnings Transcript
↗
October 30, 2025
Emergent BioSolutions (EBS) Earnings Transcript
Via
The Motley Fool
Topics
Bonds
Earnings
These stocks are moving in today's session
↗
October 30, 2025
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.
Via
Chartmill
Here are the top movers in Thursday's session.
↗
October 30, 2025
Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
October 30, 2025
Via
Benzinga
The market is filled with gapping stocks in Thursday's session.
↗
October 30, 2025
Today's session on Thursday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via
Chartmill
Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big Stocks Moving Higher On Thursday
↗
October 30, 2025
Via
Benzinga
Retail Traders Turn Ultra-Bullish On Emergent BioSolutions After Surprise Q3 Profit
↗
October 30, 2025
Shares of Emergent BioSolutions jumped 18% in after-hours trading after the company posted stronger-than-expected Q3 results and raised its full-year guidance.
Via
Stocktwits
What's going on in today's after hours session
↗
October 29, 2025
The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
October 29, 2025
Via
Benzinga
Emergent BioSolutions Reports Third Quarter 2025 Financial Results
October 29, 2025
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Releases New Survey Findings Revealing Heightened Concerns About Biological Threats and U.S. Preparedness
October 28, 2025
Policy opinion leaders believe a biological attack is both more likely and easier to execute than a nuclear strike, highlighting concerns around bioterrorism and the nation’s readiness to respond
From
Emergent BioSolutions
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
